Neurologix Inc.
One Bridge Plaza
Fort Lee,
NJ 07024
United States - Map
Phone: 201-592-6451
Fax: 203-661-1331
Web Site: http://www.neurologix.net
| Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The companys treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinsons disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitive, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntingtons disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. John E. Mordock , 63
Chief Exec. Officer, Pres |
$
275.00K | N/A | Mr. Marc L. Panoff , 38
Chief Financial Officer, Sec. and Treasurer |
$
203.00K | N/A | Dr. Christine V. Sapan Ph.D, 61
Chief Devel. Officer and Exec. VP |
$
264.00K | N/A | Dr. Matthew J. During M.D, D.Sc,
Founder and Member of Scientific Advisory Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
